Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Fatigue 7Neoplasms 4Brain Neoplasms 3Depression 2Asthenia 2Recurrence 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 8Temozolomide 7Lomustine 6Procarbazine 4Carmustine 4Bevacizumab 4Vincristine 3Surgical Procedures, Operative 2Administration, Oral 2vorasidenib 1fluorodopa F 18 1contrast agent BR1 1carmustine, poliferprosan 20 drug combination 1Valproic Acid 1Tranexamic Acid 1Trabedersen 1TIC10 compound 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Microbubbles 1Methylphenidate 1Methods 1Isotretinoin 1Infusions, Intravenous 1IL13-PE38 1Fentanyl 1Eflornithine 1Drug Delivery Systems 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Glioma × Methylphenidate × Clear all
NCT00031798 2021-09-09

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Terminated
CNSSarcoma

Astrocytoma, Brain Neoplasms, Depression, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡